ArticleEuropean journal of pediatrics2026
Rarely involved and high damage-burden joints in juvenile idiopathic arthritis: insights from the elbow, temporomandibular joint, cervical spine, hip, and shoulder.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study is to characterize clinical features, treatment patterns, and outcomes of rare and/or high damage-burden joints in juvenile idiopathic arthritis (JIA). Patients diagnosed with JIA between January 2008 and June 2025 were included in this retrospective study. Joints involved in less than 10% of the cohort were defined as "rarely involved," and joints contributing to the total JADI-A score of the cohort were defined as "high damage-burden" joints. Among 155 patients included, temporomandibular joint (TMJ) (7.7%), cervical spine (3.9%), and shoulder (1.9%) were defined as rarely involved joints. The joints contributing most to the total JADI-A score of the cohort, including TMJ (29%), elbow (29%), and hip (19.4%), were defined as high damage-burden joints. Polyarticular disease course was the most common pattern for elbow and TMJ involvement, whereas enthesitis-related arthritis was common for hip involvement. Patients with either one of these five involvements experienced more extensive involvement, more frequent articular relapses, and higher disease activity, frequent use of bDMARDs, and rarely achieved remission off medication (ROM) (p < 0.05). Polyarticular disease course and higher ESR at diagnosis were associated with higher odds of high damage-burden joint involvement (p < 0.05).
conclusionElbow, hip, TMJ, cervical spine, and shoulder are rare and/or high damage-burden joints of JIA. These joint involvements seem to relate to higher disease activity, more extensive disease, arthritis relapses, frequent use of bDMARDs, rare achievement of ROM, and a risk for joint damage. More extensive inflammatory disease may predispose to involvement of rare and/or high damage-burden joints. WHAT IS KNOWN: • Advances in the treatment of JIA, particularly the more widespread use of biologics, have led to significant improvements in long-term outcomes. • Suboptimal results are still encountered in JIA patients, even in the "biologic era." WHAT IS NEW: • Temporomandibular joint (TMJ), cervical spine, and shoulder are among the least frequently involved joints in JIA, while TMJ, elbow, and hip are associated with a high damage burden. • These five joints seem to relate to higher disease activity, more extensive disease, articular relapses, frequent use of biologic agents, rare achievement of remission off medication, and a risk of joint damage.
Indexed as
Identifiers
42911422What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.